LXEO in the 13F filings
Lexeo Therapeutics Inc · CUSIP 52886X107
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 18 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 18
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 2 listed it in both
- Shares listed
- 17,864,582
- combined, among listed positions
- Reported value
- $103m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 10 buyers (opened or added shares) and 12 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -1,922,141.
Managers listing LXEO in Q1 2026
18 of 18 holders
Largest increases and reductions, by shares
Increases
- Millennium Management LLCexisting position · 1,612,780 shares now+704,756
- Squarepoint Ops LLCexisting position · 319,090 shares now+226,482
- ExodusPoint Capital Management LPnew position · 112,172 shares now+112,172
- Wellington Management Group LLPexisting position · 172,703 shares now+89,473
- Citadel Advisors LLCexisting position · 3,834,999 shares now+60,682
Reductions
- Janus Henderson Group Ltdexisting position · 4,976,429 shares now-533,206
- D. E. Shaw & Co.existing position · 30,477 shares now-449,728
- Woodline Partners LPexisting position · 2,750,532 shares now-447,228
- Invesco Ltdexisting position · 63,518 shares now-399,511
- Two Sigma Investments LPexisting position · 181,676 shares now-218,891
New positions and exits
New (2)
Exited (5)
- Verition Fund Management LLCwas $4.3m
- Renaissance Technologies LLCwas $2.2m
- Jane Street Group LLCwas $1.4m
- Acadian Asset Management LLCwas $505k
- Winton Group Ltdwas $267k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2023 | 2 | $65m | 2 | 0 |
| Q1 2024 | 2 | $79m | 1 | 0 |
| Q2 2024 | 3 | $104m | 2 | 0 |
| Q3 2024 | 3 | $64m | 2 | 0 |
| Q4 2024 | 2 | $20m | 1 | 1 |
| Q1 2025 | 1 | $3.4m | 0 | 1 |
| Q2 2025 | 2 | $14m | 1 | 0 |
| Q3 2025 | 3 | $64m | 1 | 0 |
| Q4 2025 | 2 | $86m | 16 | 9 |
| Q1 2026 | 1 | $16m | 10 | 12 |
| Q2 2026 | 1 | $12m | 10 | 10 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
LXEO and GILD →LXEO and AMGN →LXEO and ARGX →Choose a stock to compare with LXEO →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own LXEO, latest filings →Back to the 13F Explorer →